Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02769299 · ClinicalTrials.gov registry record
Cardiotoxicity of Radiation Therapy (CTRT)
A clinical trial, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- 147
- Enrollment target
NCT02769299 is a clinical trial that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 147 participants.
The verdict
NCT02769299 has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- 147 participants
- Enrollment target
Study Summary
The overall objective of this proposal is to determine the utility of sensitive imaging and biomarker measures in detecting subclinical cardiotoxicity across a spectrum of radiation doses to the heart. We will focus specifically on patients receiving photon or proton chest radiotherapy. Our broad working hypothesis is that RT induces early, subclinical CV injury, as evidenced by cardiomyocyte inflammation and necrosis, and worsening CV function.
Interventions
- RADIATION Radiation Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 147 participants |
| Start Date | 2015-06-02 |
| Est. Completion | 2018-11-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02769299
The ClinicalTrials.gov registry entry for NCT02769299 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 147 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Radiation Therapy is the first listed.
NCT02769299 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02769299 about?
NCT02769299 is a clinical study titled "Cardiotoxicity of Radiation Therapy (CTRT)". The overall objective of this proposal is to determine the utility of sensitive imaging and biomarker measures in detecting subclinical cardiotoxicity across a spectrum of radiation doses to the heart. We will focus specifically on patients receiving photon or proton chest radiotherapy. Our broad wo...
What is the current status of trial NCT02769299?
This trial is currently completed. The enrollment target is 147 participants. The study started on 2015-06-02. Estimated completion is 2018-11-26.
What interventions are being tested in trial NCT02769299?
The interventions under investigation include: Radiation Therapy (RADIATION).
Who is sponsoring clinical trial NCT02769299?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.